Clearstead Advisors, LLC Abbott Laboratories Transaction History

Clearstead Advisors, LLC

  • $6.44 Billion
  • Q4 2024

A detailed history of Clearstead Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Clearstead Advisors, LLC holds 129,589 shares of ABT stock, worth $17.6 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
129,589
Previous 129,105 0.37%
Holding current value
$17.6 Million
Previous $14.7 Million 0.42%
% of portfolio
0.23%
Previous 0.23%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025
BUY
$111.93 - $119.39 $54,174 - $57,784
484 Added 0.37%
129,589 $14.7 Million
Q3 2024

Nov 13, 2024
SELL
$100.07 - $118.13 $267,086 - $315,288
-2,669 Reduced 2.03%
129,105 $14.7 Million
Q2 2024

Aug 09, 2024
BUY
$100.73 - $112.44 $4.18 Million - $4.66 Million
41,455 Added 45.9%
131,774 $13.7 Million
Q1 2024

May 14, 2024
SELL
$109.52 - $120.96 $343,564 - $379,451
-3,137 Reduced 3.36%
90,319 $10.3 Million
Q4 2023

Feb 12, 2024
SELL
$90.19 - $110.4 $22,727 - $27,820
-252 Reduced 0.27%
93,456 $10.3 Million
Q3 2023

Nov 13, 2023
SELL
$95.53 - $114.62 $478,318 - $573,902
-5,007 Reduced 5.07%
93,708 $9.08 Million
Q3 2023

Nov 07, 2023
BUY
$95.53 - $114.62 $475,643 - $570,692
4,979 Added 5.31%
98,715 $9.56 Million
Q2 2023

Aug 07, 2023
BUY
$100.78 - $112.29 $427,105 - $475,885
4,238 Added 4.74%
93,736 $10.2 Million
Q1 2023

May 09, 2023
BUY
$96.86 - $114.01 $114,197 - $134,417
1,179 Added 1.33%
89,498 $9.06 Million
Q4 2022

Feb 14, 2023
BUY
$95.06 - $111.52 $27,472 - $32,229
289 Added 0.33%
88,319 $9.7 Million
Q3 2022

Nov 14, 2022
SELL
$96.76 - $112.03 $244,028 - $282,539
-2,522 Reduced 2.79%
88,030 $8.52 Million
Q2 2022

Aug 12, 2022
BUY
$102.07 - $123.37 $83,187 - $100,546
815 Added 0.91%
90,552 $9.84 Million
Q1 2022

May 04, 2022
BUY
$114.02 - $139.04 $18,129 - $22,107
159 Added 0.18%
89,737 $10.6 Million
Q4 2021

Feb 14, 2022
BUY
$115.53 - $141.46 $265,603 - $325,216
2,299 Added 2.63%
89,578 $12.6 Million
Q3 2021

Nov 12, 2021
SELL
$116.66 - $129.06 $276,017 - $305,355
-2,366 Reduced 2.64%
87,279 $10.3 Million
Q2 2021

Aug 12, 2021
BUY
$105.79 - $124.53 $163,445 - $192,398
1,545 Added 1.75%
89,645 $10.4 Million
Q1 2021

May 14, 2021
BUY
$108.84 - $128.23 $554,648 - $653,460
5,096 Added 6.14%
88,100 $10.6 Million
Q4 2020

Feb 11, 2021
BUY
$105.0 - $114.42 $249,480 - $271,861
2,376 Added 2.95%
83,004 $9.09 Million
Q3 2020

Nov 12, 2020
SELL
$91.64 - $111.29 $404,865 - $491,679
-4,418 Reduced 5.19%
80,628 $8.78 Million
Q2 2020

Aug 11, 2020
BUY
$76.57 - $98.0 $703,525 - $900,424
9,188 Added 12.11%
85,046 $7.78 Million
Q1 2020

May 14, 2020
SELL
$62.82 - $91.86 $188,836 - $276,131
-3,006 Reduced 3.81%
75,858 $5.99 Million
Q4 2019

Feb 11, 2020
BUY
$78.51 - $87.4 $97,195 - $108,201
1,238 Added 1.59%
78,864 $6.85 Million
Q3 2019

Nov 12, 2019
SELL
$81.84 - $88.74 $309,928 - $336,058
-3,787 Reduced 4.65%
77,626 $6.5 Million
Q2 2019

Aug 08, 2019
BUY
$72.88 - $85.0 $7,871 - $9,180
108 Added 0.13%
81,413 $6.85 Million
Q1 2019

May 14, 2019
SELL
$66.22 - $80.06 $178,065 - $215,281
-2,689 Reduced 3.2%
81,305 $6.5 Million
Q4 2018

Feb 11, 2019
SELL
$65.56 - $74.27 $162,195 - $183,743
-2,474 Reduced 2.86%
83,994 $6.08 Million
Q3 2018

Nov 13, 2018
SELL
$60.81 - $73.36 $95,410 - $115,101
-1,569 Reduced 1.78%
86,468 $6.34 Million
Q2 2018

Aug 07, 2018
BUY
$57.57 - $63.54 $158,893 - $175,370
2,760 Added 3.24%
88,037 $5.37 Million
Q1 2018

May 14, 2018
SELL
$56.27 - $63.62 $124,300 - $140,536
-2,209 Reduced 2.52%
85,277 $5.11 Million
Q4 2017

Feb 09, 2018
SELL
$53.68 - $57.47 $96,462 - $103,273
-1,797 Reduced 2.01%
87,486 $4.99 Million
Q3 2017

Nov 09, 2017
BUY
$48.06 - $53.64 $4.29 Million - $4.79 Million
89,283
89,283 $4.76 Million

Others Institutions Holding ABT

# of Institutions
3,366
Shares Held
1.36B
Call Options Held
10.6M
Put Options Held
8.73M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $238B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Clearstead Advisors, LLC Portfolio

Follow Clearstead Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email